Case Report: Severe Peripartum Cardiac Disease in Myotonic Dystrophy Type 1
暂无分享,去创建一个
H. Lochmüller | P. Bourque | S. Chih | M. Lamacie | A. Breiner | J. Warman-Chardon | J. Zwicker | Georgia Besant | I. Smith
[1] P. Ponikowski,et al. Pathophysiology, diagnosis and management of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathy , 2019, European journal of heart failure.
[2] J. Saw,et al. Spontaneous coronary artery dissection: a review of complications and management strategies , 2019, Expert review of cardiovascular therapy.
[3] M. Honigberg,et al. Peripartum cardiomyopathy , 2019, British Medical Journal.
[4] Jin-Sung Park,et al. Diastolic heart dysfunction is correlated with CTG repeat length in myotonic dystrophy type 1 , 2018, Neurological Sciences.
[5] J. Saw,et al. Spontaneous Coronary Artery Dissection: Current State of the Science: A Scientific Statement From the American Heart Association. , 2018, Circulation.
[6] D. Hilfiker-Kleiner,et al. Pregnancy and Heart Disease: Pregnancy-Associated Hypertension and Peripartum Cardiomyopathy. , 2017, Current problems in cardiology.
[7] Paul J. Wang,et al. Management of Cardiac Involvement Associated With Neuromuscular Diseases: A Scientific Statement From the American Heart Association. , 2017, Circulation.
[8] A. Lazarus,et al. Association Between Mutation Size and Cardiac Involvement in Myotonic Dystrophy Type 1: An Analysis of the DM1-Heart Registry , 2017, Circulation. Cardiovascular genetics.
[9] G. Tomaselli,et al. Left Ventricular Dysfunction and Conduction Disturbances in Patients With Myotonic Muscular Dystrophy Type I and II , 2017, JAMA cardiology.
[10] J. Saw,et al. Contemporary Review on Spontaneous Coronary Artery Dissection. , 2016, Journal of the American College of Cardiology.
[11] C. Richards,et al. Results from an external proficiency testing program: 11 years of molecular genetics testing for myotonic dystrophy type 1 , 2016, Genetics in Medicine.
[12] C. Heatwole,et al. The Impact of Pregnancy on Myotonic Dystrophy: A Registry-Based Study , 2015, Journal of neuromuscular diseases.
[13] V. Feigin,et al. Prevalence of Muscular Dystrophies: A Systematic Literature Review , 2014, Neuroepidemiology.
[14] L. Køber,et al. High prevalence of cardiac involvement in patients with myotonic dystrophy type 1: a cross-sectional study. , 2014, International journal of cardiology.
[15] J. Saw,et al. Spontaneous coronary artery dissection: prevalence of predisposing conditions including fibromuscular dysplasia in a tertiary center cohort. , 2013, JACC. Cardiovascular interventions.
[16] L. Køber,et al. Cardiac manifestations of myotonic dystrophy type 1. , 2012, International journal of cardiology.
[17] K. Zerres,et al. Pregnancy course and outcome in women with hereditary neuromuscular disorders: comparison of obstetric risks in 178 patients. , 2012, European journal of obstetrics, gynecology, and reproductive biology.
[18] Changyu Shen,et al. Increased mortality with left ventricular systolic dysfunction and heart failure in adults with myotonic dystrophy type 1. , 2010, American heart journal.
[19] Y. Pinto,et al. Hereditary muscular dystrophies and the heart , 2010, Neuromuscular Disorders.
[20] K. Sliwa,et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy , 2010, European journal of heart failure.
[21] Pedagógia,et al. Cross Sectional Study , 2019 .
[22] A. Sovari,et al. Cardiovascular Manifestations of Myotonic Dystrophy-1 , 2007, Cardiology in review.
[23] Richard B Devereux,et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardio , 2005, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[24] Santiago Reyes,et al. Transgenic overexpression of human DMPK accumulates into hypertrophic cardiomyopathy, myotonic myopathy and hypotension traits of myotonic dystrophy. , 2004, Human molecular genetics.
[25] K. Zerres,et al. Outcome in pregnancies complicated by myotonic dystrophy: a study of 31 patients and review of the literature. , 2004, European journal of obstetrics, gynecology, and reproductive biology.
[26] Teresa Foo,et al. : SYSTEMATIC LITERATURE REVIEW , 2004 .
[27] P. Merlet,et al. Blunted coronary reserve in myotonic dystrophy. An early and gene-related phenomenon. , 1996, Circulation.
[28] David E. Housman,et al. Molecular basis of myotonic dystrophy: Expansion of a trinucleotide (CTG) repeat at the 3′ end of a transcript encoding a protein kinase family member , 1992, Cell.
[29] J. Power,et al. Severe congestive heart failure and cardiomyopathy as a complication of myotonic dystrophy in pregnancy , 1990, Obstetrics and gynecology.
[30] M. Aminoff,et al. Autonomic function in myotonic dystrophy. , 1985, Archives of neurology.
[31] R. Newcombe,et al. Blood pressure and myotonic dystrophy , 1983, Clinical genetics.
[32] F. Nuttall,et al. Thin Muscle Capillary Basement Membranes in Myotonic Dystrophy , 1979, Diabetes.
[33] P. Freedson,et al. Scientific Statement From the American Heart Association Guide to the Assessment of Physical Activity: Clinical and Research Applications: A , 2015 .